199 related articles for article (PubMed ID: 23841945)
1. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Manning D; Settle P; Gupta R; Newland P; Weindling AM
Trials; 2013 Jul; 14():211. PubMed ID: 23841945
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng SM; Turner MA; Weindling AM
Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
[No Abstract] [Full Text] [Related]
3. Effect of thyroxine on brain microstructure in extremely premature babies: magnetic resonance imaging findings in the TIPIT study.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Atkinson J; Sluming V; Parkes LM; Tietze A; Abernethy LJ; Weindling AM
Pediatr Radiol; 2014 Aug; 44(8):987-96. PubMed ID: 24671720
[TBL] [Abstract][Full Text] [Related]
4. TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Malamateniou C; Parkes LM; Tietze A; Gregory L; Sluming V; Abernethy L; Weindling AM
BMC Pediatr; 2008 Jun; 8():26. PubMed ID: 18590560
[TBL] [Abstract][Full Text] [Related]
5. TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Weindling AM
Trials; 2008 Mar; 9():17. PubMed ID: 18366798
[TBL] [Abstract][Full Text] [Related]
6. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
7. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
8. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
9. Magnesium supplementation in pregnancy.
Makrides M; Crosby DD; Bain E; Crowther CA
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000937. PubMed ID: 24696187
[TBL] [Abstract][Full Text] [Related]
10. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies).
Costeloe KL; Hennessy EM; Haider S; Stacey F; Marlow N; Draper ES
BMJ; 2012 Dec; 345():e7976. PubMed ID: 23212881
[TBL] [Abstract][Full Text] [Related]
11. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies.
Moore T; Hennessy EM; Myles J; Johnson SJ; Draper ES; Costeloe KL; Marlow N
BMJ; 2012 Dec; 345():e7961. PubMed ID: 23212880
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound Measurements of Thyroid Gland Volume at 36 Weeks' Corrected Gestational Age in Extremely Preterm Infants Born before 28 Weeks' Gestation.
Ng SM; Turner MA; Avula S
Eur Thyroid J; 2018 Jan; 7(1):21-26. PubMed ID: 29594050
[TBL] [Abstract][Full Text] [Related]
13. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
[TBL] [Abstract][Full Text] [Related]
14. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
[TBL] [Abstract][Full Text] [Related]
15. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
[TBL] [Abstract][Full Text] [Related]
16. Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial.
Gupta S; Juszczak E; Hardy P; Subhedar N; Wyllie J; Kelsall W; Sinha S; Johnson S; Roberts T; Hutchison E; Pepperell J; Linsell L; Bell JL; Stanbury K; Laube M; Edwards C; Field D;
BMC Pediatr; 2021 Feb; 21(1):100. PubMed ID: 33637074
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
[TBL] [Abstract][Full Text] [Related]
19. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.
Cooper C; Harvey NC; Bishop NJ; Kennedy S; Papageorghiou AT; Schoenmakers I; Fraser R; Gandhi SV; Carr A; D'Angelo S; Crozier SR; Moon RJ; Arden NK; Dennison EM; Godfrey KM; Inskip HM; Prentice A; Mughal MZ; Eastell R; Reid DM; Javaid MK;
Lancet Diabetes Endocrinol; 2016 May; 4(5):393-402. PubMed ID: 26944421
[TBL] [Abstract][Full Text] [Related]
20. Establishment of hormone reference intervals for infants born < 30 weeks' gestation.
Greaves RF; Zacharin MR; Donath SM; Inder TE; Doyle LW; Hunt RW
Clin Biochem; 2014 Oct; 47(15):101-8. PubMed ID: 24927648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]